The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Estradiol Transdermal System Market Research Report 2025
Synopsis
Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
The global Estradiol Transdermal System market was valued at US$ 316 million in 2023 and is anticipated to reach US$ 463.4 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Estradiol Transdermal System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Estradiol Transdermal System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Estradiol Transdermal System include Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals and Perrigo Pharma International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Estradiol Transdermal System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estradiol Transdermal System.
Report Scope
The Estradiol Transdermal System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Estradiol Transdermal System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estradiol Transdermal System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
Segment by Type
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Segment by Application
Hot Flashes
Prevention of Postmenopausal Osteoporosis
Treatment of Hypoestrogenism
Moderate-To-Severe Vasomotor Symptoms
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Estradiol Transdermal System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Estradiol Transdermal System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
The global Estradiol Transdermal System market was valued at US$ 316 million in 2023 and is anticipated to reach US$ 463.4 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Estradiol Transdermal System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Estradiol Transdermal System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Estradiol Transdermal System include Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals and Perrigo Pharma International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Estradiol Transdermal System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estradiol Transdermal System.
Report Scope
The Estradiol Transdermal System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Estradiol Transdermal System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estradiol Transdermal System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
Segment by Type
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Segment by Application
Hot Flashes
Prevention of Postmenopausal Osteoporosis
Treatment of Hypoestrogenism
Moderate-To-Severe Vasomotor Symptoms
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Estradiol Transdermal System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Estradiol Transdermal System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Estradiol Transdermal System Market Overview
1.1 Product Overview and Scope of Estradiol Transdermal System
1.2 Estradiol Transdermal System Segment by Type
1.2.1 Global Estradiol Transdermal System Market Value Comparison by Type (2024-2030)
1.2.2 0.025 mg per day
1.2.3 0.0375 mg per day
1.2.4 0.05 mg per day
1.2.5 0.075 mg per day
1.2.6 0.1 mg per day
1.3 Estradiol Transdermal System Segment by Application
1.3.1 Global Estradiol Transdermal System Market Value by Application: (2024-2030)
1.3.2 Hot Flashes
1.3.3 Prevention of Postmenopausal Osteoporosis
1.3.4 Treatment of Hypoestrogenism
1.3.5 Moderate-To-Severe Vasomotor Symptoms
1.3.6 Others
1.4 Global Estradiol Transdermal System Market Size Estimates and Forecasts
1.4.1 Global Estradiol Transdermal System Revenue 2019-2030
1.4.2 Global Estradiol Transdermal System Sales 2019-2030
1.4.3 Global Estradiol Transdermal System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Estradiol Transdermal System Market Competition by Manufacturers
2.1 Global Estradiol Transdermal System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Estradiol Transdermal System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Estradiol Transdermal System Average Price by Manufacturers (2019-2024)
2.4 Global Estradiol Transdermal System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Estradiol Transdermal System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estradiol Transdermal System, Product Type & Application
2.7 Estradiol Transdermal System Market Competitive Situation and Trends
2.7.1 Estradiol Transdermal System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Estradiol Transdermal System Players Market Share by Revenue
2.7.3 Global Estradiol Transdermal System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Estradiol Transdermal System Retrospective Market Scenario by Region
3.1 Global Estradiol Transdermal System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Estradiol Transdermal System Global Estradiol Transdermal System Sales by Region: 2019-2030
3.2.1 Global Estradiol Transdermal System Sales by Region: 2019-2024
3.2.2 Global Estradiol Transdermal System Sales by Region: 2025-2030
3.3 Global Estradiol Transdermal System Global Estradiol Transdermal System Revenue by Region: 2019-2030
3.3.1 Global Estradiol Transdermal System Revenue by Region: 2019-2024
3.3.2 Global Estradiol Transdermal System Revenue by Region: 2025-2030
3.4 North America Estradiol Transdermal System Market Facts & Figures by Country
3.4.1 North America Estradiol Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Estradiol Transdermal System Sales by Country (2019-2030)
3.4.3 North America Estradiol Transdermal System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Estradiol Transdermal System Market Facts & Figures by Country
3.5.1 Europe Estradiol Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Estradiol Transdermal System Sales by Country (2019-2030)
3.5.3 Europe Estradiol Transdermal System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estradiol Transdermal System Market Facts & Figures by Country
3.6.1 Asia Pacific Estradiol Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Estradiol Transdermal System Sales by Country (2019-2030)
3.6.3 Asia Pacific Estradiol Transdermal System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Estradiol Transdermal System Market Facts & Figures by Country
3.7.1 Latin America Estradiol Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Estradiol Transdermal System Sales by Country (2019-2030)
3.7.3 Latin America Estradiol Transdermal System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Estradiol Transdermal System Market Facts & Figures by Country
3.8.1 Middle East and Africa Estradiol Transdermal System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Estradiol Transdermal System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Estradiol Transdermal System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Estradiol Transdermal System Sales by Type (2019-2030)
4.1.1 Global Estradiol Transdermal System Sales by Type (2019-2024)
4.1.2 Global Estradiol Transdermal System Sales by Type (2025-2030)
4.1.3 Global Estradiol Transdermal System Sales Market Share by Type (2019-2030)
4.2 Global Estradiol Transdermal System Revenue by Type (2019-2030)
4.2.1 Global Estradiol Transdermal System Revenue by Type (2019-2024)
4.2.2 Global Estradiol Transdermal System Revenue by Type (2025-2030)
4.2.3 Global Estradiol Transdermal System Revenue Market Share by Type (2019-2030)
4.3 Global Estradiol Transdermal System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Estradiol Transdermal System Sales by Application (2019-2030)
5.1.1 Global Estradiol Transdermal System Sales by Application (2019-2024)
5.1.2 Global Estradiol Transdermal System Sales by Application (2025-2030)
5.1.3 Global Estradiol Transdermal System Sales Market Share by Application (2019-2030)
5.2 Global Estradiol Transdermal System Revenue by Application (2019-2030)
5.2.1 Global Estradiol Transdermal System Revenue by Application (2019-2024)
5.2.2 Global Estradiol Transdermal System Revenue by Application (2025-2030)
5.2.3 Global Estradiol Transdermal System Revenue Market Share by Application (2019-2030)
5.3 Global Estradiol Transdermal System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Estradiol Transdermal System Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Estradiol Transdermal System Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Estradiol Transdermal System Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Noven Therapeutics
6.4.1 Noven Therapeutics Corporation Information
6.4.2 Noven Therapeutics Description and Business Overview
6.4.3 Noven Therapeutics Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Noven Therapeutics Estradiol Transdermal System Product Portfolio
6.4.5 Noven Therapeutics Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Estradiol Transdermal System Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Vertical Pharmaceuticals
6.6.1 Vertical Pharmaceuticals Corporation Information
6.6.2 Vertical Pharmaceuticals Description and Business Overview
6.6.3 Vertical Pharmaceuticals Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vertical Pharmaceuticals Estradiol Transdermal System Product Portfolio
6.6.5 Vertical Pharmaceuticals Recent Developments/Updates
6.7 Perrigo Pharma International
6.6.1 Perrigo Pharma International Corporation Information
6.6.2 Perrigo Pharma International Description and Business Overview
6.6.3 Perrigo Pharma International Estradiol Transdermal System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Perrigo Pharma International Estradiol Transdermal System Product Portfolio
6.7.5 Perrigo Pharma International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estradiol Transdermal System Industry Chain Analysis
7.2 Estradiol Transdermal System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estradiol Transdermal System Production Mode & Process
7.4 Estradiol Transdermal System Sales and Marketing
7.4.1 Estradiol Transdermal System Sales Channels
7.4.2 Estradiol Transdermal System Distributors
7.5 Estradiol Transdermal System Customers
8 Estradiol Transdermal System Market Dynamics
8.1 Estradiol Transdermal System Industry Trends
8.2 Estradiol Transdermal System Market Drivers
8.3 Estradiol Transdermal System Market Challenges
8.4 Estradiol Transdermal System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
